DOSTARLIMAB-GXLY vs DOXYCYCLINE HYCLATE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DOSTARLIMAB-GXLY vs DOXYCYCLINE HYCLATE: Safety Overview
| Metric | DOSTARLIMAB-GXLY | DOXYCYCLINE HYCLATE |
|---|---|---|
| Total FAERS Reports | 504 | 6,098 |
| Deaths Reported | 55 | 1,164 |
| Death Rate | 10.9% | 19.1% |
| Hospitalizations | 126 | 1,650 |
| Average Patient Age | 67.4 yrs | 53.6 yrs |
| % Female Patients | 92.7% | 72.6% |
| FDA Approval Date | N/A | Approved Prior to Jan 1, 1982 |
| Manufacturer | N/A | A-S Medication Solutions |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Discontinued |